MPO and chronic granulomatous disease: by phagocytes since invasive disease has been documented in patients with chronic granulomatous disease (CGD) (Moylett et al., 2003; Wynne et al., 2004), and because defective myeloperoxidase-dependent oxidative systems were found to increase susceptibility to experimental T. asahii infection (Aratani et al., 2000).